Physician profile
Cortnee Kelly
NPI 1457612442
$3,422.38
in general payments reported to CMS, 2019-2025
19 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $711 · 2022: $1,672 · 2023: $259 · 2024: $490 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $775.19 | 2022-2025 | Camzyos |
| Boston Scientific Corporation | $415.95 | 2021-2025 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $361.50 | 2021-2024 | Lifevest |
| Abiomed | $262.98 | 2022 | |
| Janssen Pharmaceuticals, INC | $261.18 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $250.48 | 2021-2022 | |
| Medtronic, INC. | $234.69 | 2021-2022 | |
| Esperion Therapeutics, INC. | $131.71 | 2021-2024 | Nexletol |
| Mayne Pharma Commercial LLC | $125.00 | 2022 | |
| Janssen Scientific Affairs, LLC | $124.99 | 2022 | |
| Abbott Laboratories | $119.81 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.04 | 2021-2025 | Jardiance |
| Haemonetics Corporation | $96.94 | 2022 | |
| Gilead Sciences, INC. | $68.13 | 2022 | |
| Novartis Pharmaceuticals Corporation | $28.08 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.67 | 2025 | |
| Merck Sharp & Dohme LLC | $14.07 | 2024 | |
| Bard Peripheral Vascular, INC. | $13.19 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $12.78 | 2024 | Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cortnee Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.